Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-13 4:00 pm Unchanged | 13G | PROFOUND MED CORP COM PROF | DASEKE DON R | 1,105,000 4.5% | 0 (Unchanged) | View |
| 2024-02-13 4:06 pm Sale | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 2,891,423 13.5% | -245,405 (-7.82%) | View |
| 2024-02-12 2:37 pm Sale | 13G | PROFOUND MED CORP COM PROF | LETKO BROSSEAU & ASSOCIATES INC | 1,177,850 5.5% | -2,575 (-0.22%) | View |
| 2024-02-09 07:59 am Sale | 13G | PROFOUND MED CORP COM PROF | FIL Ltd | 1,200,635 5.619% | -65,090 (-5.14%) | View |
| 2024-01-11 4:42 pm Purchase | 13G | PROFOUND MED CORP COM PROF | DASEKE DON R | 1,105,000 5.2% | 1,105,000 (New Position) | View |
| 2023-02-13 4:05 pm Purchase | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 3,136,828 15% | 12,464 (+0.40%) | View |
| 2023-02-10 10:08 am Sale | 13G | PROFOUND MED CORP COM PROF | Flynn James E | 0 0% | -1,713,797 (Position Closed) | View |
| 2023-02-09 5:42 pm Purchase | 13G | PROFOUND MED CORP COM PROF | LETKO BROSSEAU & ASSOCIATES INC | 1,180,425 5.7% | 1,180,425 (New Position) | View |
| 2023-02-09 07:57 am Purchase | 13G | PROFOUND MED CORP COM PROF | FIL Ltd | 1,265,725 6.051% | 200,300 (+18.80%) | View |
| 2023-02-06 4:09 pm Sale | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 3,124,364 15% | -57,378 (-1.80%) | View |
| 2022-10-11 4:10 pm Purchase | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 3,181,742 15.3% | 1,103,713 (+53.11%) | View |
| 2022-03-10 4:05 pm Purchase | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 2,078,029 10% | 216,810 (+11.65%) | View |
| 2022-02-14 5:21 pm Sale | 13G | PROFOUND MED CORP COM PROF | Genesys Ventures II LP | 455,738 2.19% | -153,745 (-25.23%) | View |
| 2022-02-11 4:13 pm Purchase | 13G | PROFOUND MED CORP COM PROF | Flynn James E | 1,713,797 8.25% | 673,376 (+64.72%) | View |
| 2022-02-09 08:58 am Sale | 13G | PROFOUND MED CORP COM PROF | FIL Ltd | 1,065,425 5.119% | -79,710 (-6.96%) | View |
| 2022-02-03 4:31 pm Unchanged | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 1,861,219 9% | 0 (Unchanged) | View |
| 2022-02-03 4:29 pm Purchase | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 1,861,219 9% | 450,593 (+31.94%) | View |
| 2021-02-16 4:35 pm Sale | 13G | PROFOUND MED CORP COM PROF | Genesys Ventures II LP | 609,483 3.11% | -300,604 (-33.03%) | View |
| 2021-02-09 4:11 pm Purchase | 13G | PROFOUND MED CORP COM PROF | GAGNON SECURITIES LLC | 1,410,626 7.2% | 44,915 (+3.29%) | View |
| 2021-02-08 10:05 am Sale | 13G | PROFOUND MED CORP COM PROF | FIL Ltd | 1,145,135 5.821% | -25,265 (-2.16%) | View |